RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting
- DOI
- 10.1038/s41417-022-00459-0
- Published
- 2022-03-30
- Container
- Cancer Gene Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41417-022-00459-0,
title = {RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting},
author = {Yichu Nie and Fenglan Feng and Wei Luo and Andrew J. Sanders and Yidi Zhang and Jiaming Liang and Cheng Chen and Weineng Feng and Weiquan Gu and Weiping Liao and Wei Wang and Jinfeng Chen and Lijian Zhang and Wen G. Jiang and Jin Li},
year = {2022},
journal = {Cancer Gene Therapy},
doi = {10.1038/s41417-022-00459-0},
url = {https://doi.org/10.1038/s41417-022-00459-0}
}RIS
TY - JOUR TI - RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting AU - Yichu Nie AU - Fenglan Feng AU - Wei Luo AU - Andrew J. Sanders AU - Yidi Zhang AU - Jiaming Liang AU - Cheng Chen AU - Weineng Feng AU - Weiquan Gu AU - Weiping Liao AU - Wei Wang AU - Jinfeng Chen AU - Lijian Zhang AU - Wen G. Jiang AU - Jin Li PY - 2022 JO - Cancer Gene Therapy DO - 10.1038/s41417-022-00459-0 UR - https://doi.org/10.1038/s41417-022-00459-0 ER -
APA
Nie, Y., Feng, F., Luo, W., Sanders, A. J., Zhang, Y., Liang, J., Chen, C., Feng, W., Gu, W., Liao, W., Wang, W., Chen, J., Zhang, L., Jiang, W. G., & Li, J. (2022). RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting. Cancer Gene Therapy. https://doi.org/10.1038/s41417-022-00459-0
Source records
- crossref · retrieved 2026-09-26T18:23:53.516Z